𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sa1933 Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy

✍ Scribed by Casanova, Maria José; Chaparro, Maria; Domenech, Eugeni; Acosta, Manuel Barreiro-de; Bermejo, Fernando; Flores, Eva Iglesias; Gomollón, Fernando; Rodrigo, Luis; Calvet, Xavier; Esteve, Maria; Garcia, Esther; Garcia, S.; Taxonera, Carlos; Calvo, Marta; Lopez, M.; Ginard, Daniel; Gómez, Maria; Garrido, Elena; Pérez-Calle, José L.; Beltran, Belen; Piqueras, Marta; Saro, Cristina; Botella, Belén; Duenas, Carmen; Diaz, Angel Ponferrada; Manosa, Miriam; Iglesias, Marta; Algaba, Alicia; Garcia-Sânchez, Valle; Mate, J.; Gisbert, Javier P.

Book ID
122288692
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
77 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of immunomodulators and biologics
Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding
✍ Javier P. Gisbert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

The aim of this article is to critically review available data regarding the safety of immunomodulators and biological therapies during pregnancy and breast-feeding in women with inflammatory bowel disease. Methotrexate and thalidomide can cause congenital anomalies and are contraindicated during pr